Published date: 19 December 2019
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Medical equipments, pharmaceuticals and personal care products - 33000000
Pharmaceutical products - 33600000
Location of contract
South West
Value of contract
£70,000
Procurement reference
tender_228487/824262
Published date
19 December 2019
Closing date
20 January 2020
Contract start date
31 January 2020
Contract end date
31 January 2021
Contract type
Supply contract
Procedure type
Open procedure (below threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
STRATA Clinical Trial - Seteraline drug and placebo for a Clinical Trial; Autism in adults in the UK and Australia. Anxiety is common in adults with a diagnosis of autism and can be more disabling than the core features of autism. Medications for anxiety are often prescribed for adults with autism but their effectiveness or side effects in this population are not well known.
Aims: i) to determine the effectiveness of the Selective Serotonin Reuptake Inhibitor (SSRI) sertraline in reducing symptoms of anxiety and improving quality of life in adults with a diagnosis of autism compared with placebo and quantify its adverse effects; ii) to determine its cost effectiveness; iii) to explore patients' views and experiences of taking study medication and identify reasons for completing/not completing the study.
About the buyer
Contact name
Lucy Neaves
Address
4th Floor, Augustine's Courtyard, Orchard Lane
Bristol
BS1 5DS
England
Telephone
01173940651
Share this notice
Closing: 20 January 2020
All content is available under the
